# FDA Inspection 1181253 - Louisville Health, Louisville - Jewish Hospital - October 06, 2022

Source: https://www.keypedia.com/records/fda_inspections/louisville-health-louisville-jewish-hospital/745593f2-5928-46de-93fb-8a2544c33003
Source feed: FDA_Inspections

> FDA Inspection 1181253 for Louisville Health, Louisville - Jewish Hospital on October 06, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181253
- Company Name: Louisville Health, Louisville - Jewish Hospital
- Inspection Date: 2022-10-06
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1181253 - 2022-10-06](https://www.keypedia.com/records/fda_inspections/louisville-health-louisville-jewish-hospital/9cbadf67-8987-419a-b527-626bf6126e45)
- [FDA Inspection 1181253 - 2022-10-06](https://www.keypedia.com/records/fda_inspections/louisville-health-louisville-jewish-hospital/c73bd765-d30c-461b-bd90-9c4686802e11)

Company: https://www.keypedia.com/companies/louisville-health-louisville-jewish-hospital/e68afd64-baaf-4b92-a4b4-04ea574a0beb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d